| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 52,654 | 55,911 | 63,271 | | Cost of Revenue | 17,060 | 17,686 | 19,631 | | | Gross Profit | 35,594 | 38,225 | 43,640 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 26,171 | 23,987 | 23,878 | | Non Recurring | 12,433 | 1,150 | 533 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (3,010) | 13,088 | 19,229 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 639 | 808 | 1,305 | | Earnings Before Interest And Taxes | (2,371) | 13,896 | 20,534 | | Interest Expense | 221 | 157 | 229 | | Income Before Tax | (2,592) | 13,739 | 20,305 | | Income Tax Expense | 2,596 | 5,079 | 7,996 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,188) | 8,660 | 12,309 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (5,188) | 8,660 | 12,309 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,188) | $8,660 | $12,309 |
|
1.48% Nasdaq 
0.04 (2.22%) 
Income Statement
